The NCCOM3-R6 monitor continuously monitors cardiac output and five other cardiovascular variables from the thoracic electrical bioimpedance signal. We averaged data over 5-min intervals for 130 min in 100 control studies in 40 pediatric ICU patients, age 0.04 to 20.39 yr (median 1.39) and weighing 2.0 to 59.5 kg (median 8.8). For individual studies, 99% of the 5-min averages of cardiac output fell within +/- 44% of the baseline cardiac output for that study. Normal ranges were somewhat narrower for the other five variables. When we averaged data for 100 studies, 5-min interval observations for each variable did not deviate from baseline over a 2-h period (p greater than .70). With a sample size of 100 studies, we could detect a change in cardiac output of +/- 5% at the p less than .005 level with a power of 0.95. We conclude that with a sufficiently large sample size, studies employing the NCCOM3 can detect clinically significant cardiovascular changes due to pharmacologic or procedural stressors.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!